These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22492892)

  • 1. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse.
    Jacobs BL; Zhang Y; Skolarus TA; Hollenbeck BK
    Health Aff (Millwood); 2012 Apr; 31(4):750-9. PubMed ID: 22492892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
    Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
    J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
    Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
    Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
    Carter HE; Martin A; Schofield D; Duchesne G; Haworth A; Hornby C; Sidhom M; Jackson M
    Radiother Oncol; 2014 Aug; 112(2):187-93. PubMed ID: 24929702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer.
    Jacobs BL; Zhang Y; Skolarus TA; Wei JT; Montie JE; Schroeck FR; Hollenbeck BK
    Urology; 2012 Dec; 80(6):1236-42. PubMed ID: 23206767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
    Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
    Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
    Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
    Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
    Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
    Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
    Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC
    Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
    Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
    Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.
    Pan HY; Jiang J; Hoffman KE; Tang C; Choi SL; Nguyen QN; Frank SJ; Anscher MS; Shih YT; Smith BD
    J Clin Oncol; 2018 Jun; 36(18):1823-1830. PubMed ID: 29561693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
    Yu JB; Soulos PR; Herrin J; Cramer LD; Potosky AL; Roberts KB; Gross CP
    J Natl Cancer Inst; 2013 Jan; 105(1):25-32. PubMed ID: 23243199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
    Khanna A; Hu JC; Gu X; Nguyen PL; Lipsitz S; Palapattu GS
    J Urol; 2013 Jan; 189(1):75-9. PubMed ID: 23164382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of external-beam radiation approaches for prostate cancer.
    Jacobs BL; Zhang Y; Skolarus TA; Wei JT; Montie JE; Miller DC; Hollenbeck BK
    Eur Urol; 2014 Jan; 65(1):162-8. PubMed ID: 22790288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.
    Bekelman JE; Mitra N; Efstathiou J; Liao K; Sunderland R; Yeboa DN; Armstrong K
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e325-34. PubMed ID: 21498008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
    Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.
    Yong JH; Beca J; McGowan T; Bremner KE; Warde P; Hoch JS
    Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):521-31. PubMed ID: 22705100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.
    Cobran EK; Chen RC; Overman R; Meyer AM; Kuo TM; O'Brien J; Sturmer T; Sheets NC; Goldin GH; Penn DC; Godley PA; Carpenter WR
    Am J Mens Health; 2016 Sep; 10(5):399-407. PubMed ID: 25657192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.
    Sujenthiran A; Nossiter J; Charman SC; Parry M; Dasgupta P; van der Meulen J; Cathcart PJ; Clarke NW; Payne H; Aggarwal A
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1253-1260. PubMed ID: 28974414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.